Skip to main content

Advertisement

Table 3 Summary of Effectiveness of Gel-200 at Week 13 in Retreatment Group A and Nonretreatment Group B

From: Evidence for safety of retreatment with a single intra-articular injection of Gel-200 for treatment of osteoarthritis of the knee from the double-blind pivotal and open-label retreatment clinical trials

Outcome Nonretreatment Group B versus Retreatment Group A
Difference (95 % CI) p-value
WOMAC pain subscores 26.1 (19.2, 32.9) <0.001
WOMAC physical function subscores 23.3 (16.4, 30.2) <0.001
WOMAC stiffness subscores 23.9 (16.6, 31.2) <0.001
Total WOMAC score 23.9 (17.2, 30.6) <0.001
Patient global evaluation 23.0 (14.9, 31.2) <0.001
Physician global evaluation 17.6 (10.5, 24.7) <0.001